Lyn Thayer Denend
Lecturer, Stanford School of Medicine
Additional Administrative Titles
Teaching Statement
Bio
Lyn Denend is Director for Academic Programs at Stanford Biodesign and a Lecturer in the Stanford School of Medicine. In her Biodesign role, she leads curriculum development and program execution across Stanford Biodesign’s portfolio of educational offerings. She teaches numerous courses, including the graduate-level Biodesign Innovation class and the undergraduate Needs Finding in Healthcare program. Lyn spearheaded Stanford Biodesign’s efforts to codify its core innovation process, is the principal author of the textbook Biodesign: The Process of Innovating Medical Technologies (1st and 2nd editions), and led the development of the online teaching materials available at ebiodesign.org and biodesignguide.stanford.edu. She also helps disseminate best practices in health technology innovation education as an organizing member of the Biomedical Engineering-Innovation, Design, and Entrepreneurship Alliance (BME-IDEA) in the United States and Asia Pacific. Prior to Stanford Biodesign, she created multimedia teaching materials at the Stanford Graduate School of Business, where she authored more than 100 case studies. Lyn was a Senior Manager with Ernst Young’s management consulting practice. She earned an MBA from Duke University’s Fuqua School of Business and a BA in Communications from the University of California at Santa Barbara.
Academic Degrees
- BA, Communications, University of California at Santa Barbara, 1989
- MBA, Fuqua School of Business, Duke University, 1996
Academic Appointments
- Lecturer, Stanford School of Medicine, 2021–2024
Professional Experience
- Senior Consultant, Cap Gemini Ernst & Young (formerly Ernst & Young Consulting), 1996-2003
Awards and Honors
- Stanford Medicine, Inspiring Change Leadership Award, 2014
Publications
Journal Articles
Books
Academic Publications
Teaching
Degree Courses
Stanford Case Studies
Stanford University Affiliations
- Director for Academic Programs Stanford Biodesign 2015–present